Bg. Weinshenker et al., GENETIC-VARIATION IN THE TUMOR-NECROSIS-FACTOR-ALPHA GENE AND THE OUTCOME OF MULTIPLE-SCLEROSIS, Neurology, 49(2), 1997, pp. 378-385
The objective of this study was to determine whether sequence variatio
n in the tumor necrosis factor alpha (TNF alpha) gene is associated wi
th MS course and severity in Olmsted County, MN. The severity and temp
oral course of MS are heterogeneous. Genetic factors may play a role i
n determining the course of MS. TNF alpha expression is temporally ass
ociated with exacerbations of MS and is increased in individuals with
progressive disease. The entire TNF alpha gene was amplified by polyme
rase chain reaction in 78 MS patients and in 39 patients with schizoph
renia. Denaturation finger-printing, a modification of direct sequenci
ng that detects virtually all genetic polymorphisms, was pet-formed fo
r four regions spanning the functionally significant portions of the g
ene, including the promoter region. Polymorphisms were confirmed by co
mplete sequencing. The severity and temporal course of MS were compare
d in those with wild-type versus variant alleles. Four sequence change
s were detected, three of which occurred in MS patients. None occurred
in a protein-encoding sequence. Neither of the two most common sequen
ce variants were associated with disease severity or temporal course.
Genetic variation of the TNF alpha gene is not associated with variati
on in the course or long-term outcome of MS in this population-based s
ample.